Human fetal eyes were obtained under protocols approved by the Weill Medical College IRB and were studied in compliance with the tenets of the Declaration of Helsinki. Fetal age was determined by femur length. The cornea and lens were removed and the eyes fixed overnight at 4°C in 4% paraformaldehyde in PBS (PFA/PBS), incubated in 30% sucrose/PBS overnight at 4°C, embedded in one part 30% sucrose/PBS and two parts optimal cutting temperature compound (OCT; Miles Laboratories, Elkhart, IN), frozen, and sectioned at 10 to 15 μm.
For Rb staining, sections were postfixed in 4% PFA/PBS for 5 minutes, washed in 0.5 M NaCl/20 mM Tris (pH 8.0; TBS), treated with 1 mM EDTA/TBS for 5 minutes, washed with TBS, incubated in 0.1% H
2O
2 for 15 minutes, washed in TBS, treated with ABC kit reagent A (Vector Laboratories, Burlingame, CA) in TBS for 15 minutes, washed in TBS, treated with ABC kit reagent B (Vector Laboratories) in TBS for 15 minutes, washed in TBS, blocked and permeabilized in 5% horse serum+2% human serum in TBS (block 1), with 0.1% Triton-X-100 for 20 minutes, incubated in Rb antibody G3-245 (1:200; BD-PharMingen, San Diego, CA) in block 1+0.05% Tween-20 overnight at 4°C, washed in TBS, incubated in biotinylated horse anti-mouse antibody (1:135; Vector Laboratories) in block 1 for 30 minutes, washed in TBS, washed in 0.1 M sodium bicarbonate and 0.15 M NaCl (balanced saline), incubated with FITC-conjugated streptavidin (1:100; Vector Laboratories) in balanced saline, and washed with TBS. For costaining, sections were incubated in 5% goat serum and 2% human serum in TBS (block 2) for 20 minutes, incubated overnight with primary antibody (
Supplementary Information) in block 2, washed in TBS, incubated for 30 minutes in block 2 with secondary antibody (Supplementary Information online), and washed in TBS. Sections were stained with (4′,6′-diamino-2-phenylindole (DAPI) and analyzed by indirect immunofluorescence or confocal microscopy.